[Disseminated intravascular coagulation. II. Therapeutic problems]

Area of Science:

• Hematology
• Critical Care Medicine

Context:

• Disseminated intravascular coagulation (DIC) presents significant therapeutic challenges.
• Diagnosis is complicated by subtle symptoms and rapid disease progression.
• Management requires a multi-faceted approach addressing coagulation and organ support.

Purpose:

• To outline the complexities and essential components of managing disseminated intravascular coagulation (DIC).
• To emphasize the importance of prompt diagnosis and targeted therapy in DIC.
• To highlight the critical role of addressing both the coagulation cascade and systemic complications.

Summary:

• DIC treatment involves identifying and treating the trigger condition.
• Therapeutic strategies include anticoagulation with heparin to inhibit intravascular coagulation.
• Transfusional support with blood products and platelet concentrates is crucial for correcting consumption coagulopathy.
• Management also necessitates direct interventions for shock, cardiorespiratory compromise, and acute renal insufficiency.
• Successful outcomes depend on timely, individualized therapeutic interventions.

Impact:

• Optimizing DIC treatment protocols can improve patient survival rates.
• Understanding the pathophysiology guides rational therapeutic decision-making.
• Integrated care addressing both hematologic and organ system dysfunction is key to managing this critical illness.